A co-ultramicronized palmitoylethanolamide/luteolin composite mitigates clinical score and disease-relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitis
出版年份 2019 全文链接
标题
A co-ultramicronized palmitoylethanolamide/luteolin composite mitigates clinical score and disease-relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitis
作者
关键词
Multiple sclerosis, EAE, Acute phase response, PEALut
出版物
Journal of Neuroinflammation
Volume 16, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-06-20
DOI
10.1186/s12974-019-1514-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Multiple sclerosis
- (2018) Alan J Thompson et al. LANCET
- Enhanced endocannabinoid tone as a potential target of pharmacotherapy
- (2018) Marek Toczek et al. LIFE SCIENCES
- Resolvin D1 Halts Remote Neuroinflammation and Improves Functional Recovery after Focal Brain Damage Via ALX/FPR2 Receptor-Regulated MicroRNAs
- (2018) Elisa Bisicchia et al. MOLECULAR NEUROBIOLOGY
- The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases
- (2018) Valerio Chiurchiù et al. PROGRESS IN NEUROBIOLOGY
- Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect
- (2018) Stefania Petrosino et al. Frontiers in Pharmacology
- The Flavone Luteolin Improves Central Nervous System Disorders by Different Mechanisms: A Review
- (2018) Zeinab Ashaari et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- New approaches and challenges to targeting the endocannabinoid system
- (2018) Vincenzo Di Marzo NATURE REVIEWS DRUG DISCOVERY
- Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases
- (2018) Bo-Zong Shao et al. Frontiers in Molecular Neuroscience
- Production of PEA composite microparticles with polyvinylpyrrolidone and luteolin using Supercritical Assisted Atomization
- (2018) Renata Adami et al. JOURNAL OF SUPERCRITICAL FLUIDS
- Novel ureidopropanamide based N -formyl peptide receptor 2 (FPR2) agonists with potential application for central nervous system disorders characterized by neuroinflammation
- (2017) Madia Letizia Stama et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The contribution of the acute phase response to the pathogenesis of relapse in chronic-relapsing experimental autoimmune encephalitis models of multiple sclerosis
- (2017) Silvy Mardiguian et al. Journal of Neuroinflammation
- Co-Ultramicronized Palmitoylethanolamide/Luteolin Facilitates the Development of Differentiating and Undifferentiated Rat Oligodendrocyte Progenitor Cells
- (2017) Stephen D. Skaper et al. MOLECULAR NEUROBIOLOGY
- Anti-Inflammatory and Neuroprotective Effects of Co-UltraPEALut in a Mouse Model of Vascular Dementia
- (2017) Rosalba Siracusa et al. Frontiers in Neurology
- Expression and Differential Responsiveness of Central Nervous System Glial Cell Populations to the Acute Phase Protein Serum Amyloid A
- (2017) Massimo Barbierato et al. Scientific Reports
- The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations
- (2016) Stefania Petrosino et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells
- (2016) Ewa Kozela et al. Journal of Neuroinflammation
- Neuroprotective Effects of Co-UltraPEALut on Secondary Inflammatory Process and Autophagy Involved in Traumatic Brain Injury
- (2016) Marika Cordaro et al. JOURNAL OF NEUROTRAUMA
- Microglia activation states and cannabinoid system: Therapeutic implications
- (2016) M. Mecha et al. PHARMACOLOGY & THERAPEUTICS
- From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology
- (2016) Alessia Ligresti et al. PHYSIOLOGICAL REVIEWS
- Co-Ultramicronized Palmitoylethanolamide/Luteolin Promotes Neuronal Regeneration after Spinal Cord Injury
- (2016) Rosalia Crupi et al. Frontiers in Pharmacology
- Luteolin as an anti-inflammatory and neuroprotective agent: A brief review
- (2015) Seyed Fazel Nabavi et al. BRAIN RESEARCH BULLETIN
- Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice
- (2015) A. Rahimi et al. NEUROSCIENCE
- Co-ultramicronized Palmitoylethanolamide/Luteolin Promotes the Maturation of Oligodendrocyte Precursor Cells
- (2015) Massimo Barbierato et al. Scientific Reports
- Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man
- (2015) Carlo Caltagirone et al. Translational Stroke Research
- Neuroprotection by Association of Palmitoylethanolamide with Luteolin in Experimental Alzheimer’s Disease Models: The Control of Neuroinflammation
- (2014) Irene Paterniti et al. CNS & Neurological Disorders-Drug Targets
- To look for a needle in a haystack: the search for autoantibodies in multiple sclerosis
- (2014) Lucas Schirmer et al. Multiple Sclerosis Journal
- Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity
- (2014) P. Browne et al. NEUROLOGY
- Palmitoylethanolamide in CNS health and disease
- (2014) Giuseppina Mattace Raso et al. PHARMACOLOGICAL RESEARCH
- Effects of Palmitoylethanolamide and Luteolin in an Animal Model of Anxiety/Depression
- (2013) Rosalia Crupi et al. CNS & Neurological Disorders-Drug Targets
- Endocannabinoids: A unique opportunity to develop multitarget analgesics
- (2013) Sabatino Maione et al. PAIN
- Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain
- (2013) Stephen D. Skaper et al. INFLAMMOPHARMACOLOGY
- Development of Experimental Autoimmune Encephalomyelitis Critically Depends on CD137 Ligand Signaling
- (2012) J. M. Martinez Gomez et al. JOURNAL OF NEUROSCIENCE
- Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain
- (2010) Harald S. Hansen EXPERIMENTAL NEUROLOGY
- Cutting Edge: NF- B Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
- (2009) F. G. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started